In vitro evaluation of the hemostatic effectiveness of non viable platelet preparations: Studies with frozen-thawed, sonicated or lyophilized platelets

Vox Sanguinis

Volumn 73, Issue 1, 1997, Pages 36-42

  Alemany, Monica ^a   Hernandez, Maria Rosa ^a   Bozzo, Jordi ^a   Galan, Ana Maria ^a   Reverter, Joan Carles ^a   Mazzara, Roberto ^a   Ordinas, Antonio ^a   Escolar, Gines ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; GLYCOPROTEIN IB; GLYCOPROTEIN IIIA; LOW MOLECULAR WEIGHT HEPARIN; PADGEM PROTEIN; THROMBOCYTE CONCENTRATE;

ANTICOAGULATION; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; CRYOPRESERVATION; FIBRIN DEPOSITION; FLOW CYTOMETRY; FREEZE DRYING; HEMOSTASIS; HUMAN; HUMAN CELL; LIFESPAN; MORPHOMETRICS; PERFUSION; PRIORITY JOURNAL; SUBENDOTHELIUM; THAWING; THROMBOCYTE PRESERVATION; ULTRASOUND;

EID: 0030797169     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.1997.7310036.x     Document Type: Article

References (39)

1. Boon GD: An overview of hemostasis. Toxicol Pathol 1993;21:170-179
2. Bevers EM, Comfurius P, Zwaal RFA: Platelet procoagulant activity: Physiological significance and mechanisms of exposure. Blood Rev 1991;5:146-154.
3. Bevers EM, Comfurius P, Van Rijn JLML, Hemker HC, Zwaal RFA: Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets, Eur J Biochem 1982;122:429-436.
4. Kickler TS: Improving the quality of stored platelets. Transfusion 1991;31:1-3.
5. Hogman CF: New trends in the preparation and storage of platelets. Transfusion 1992;32:3-6.
6. Klein E, Farber S, Freeman G, Fiorentino R: The effects of a dried fraction of platelets on the calcium time of natural clotting time of normal thrombocytopenic and hemophilic plasma. Fed Proc 1955;14:1324-1329.
7. Klein E, Farber S, Djerassi I, Toch R, Freeman G, Arnold P: The preparation and clinical administration of lyophilized platelet material to children with acute leukemia and aplastic anemia. J Pediatr 1956;49:517-522.
8. Bode AP, Eick L: Lysed platelets shorten the activated coagulation time (ACT) of heparinized blood. Am J Pathol 1989;91:430-434.
9. Bode AP, Castellani WJ, Hodges EA, Yelberton S: The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT). Thromb Hemost 1991;66:213-217.
10. Baumgartner HR: The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Microvasc Res 1973;5:167-179.
11. Escolar G, Mazzara R, White JG, Castillo R, Ordinas A: Contribution of perfusion techniques to the evaluation of the hemostatic effectiveness of platelet concentrates. Blood Cells 1992:18:403-415.
12. Escolar G, Hagert-Whiting K, Bravo ML, White JG: Interaction of long-term stored platelets with vascular subendothelium. J Lab Clin Med 1987;109:147-154.
13. Mazzara R, Escolar G, Garrido M, Pereira A, Castillo R, Ordinas A: Evaluation of the transfusion effectiveness of various platelet concentrates by means of an in vitro perfusion technique Transfusion 1991;31:308-312.
14. Hernández MR, Bozzo J, Mazzara R, Ordinas A, Escolar G: Platelet concentrates promote procoagulant activity: Evidence from experimental studies using a perfusion technique. Transfusion 1995;35:660-665.
15. McGill M, Brindley DC, Effects of storage on platelet reactivity to arterial subendothelium during blood flow. J Lab Clin Med 1979;94: 370-380.
16. Owens M, Holme S, Heaton A. Sawyer S, Cardinali S: Post-transfusion recovery of function of five-day stored platelet concentrates. Br J Haematol 1992;80:539-544
17. Zwaginga JJ, Sixma JJ, de Groot PG: Activation of endothelial cells induces platelet thrombus formation on their matrix. Studies of new in vitro thrombosis model with low molecular weight heparin as anticoagulant. Arteriosclerosis 1990;18:49-61.
18. Sirchia G, Wenz B, Rebulla P, Parravicmi A, Carnelli V, Bertolini F: Removal of white cells from red cells by transfusion through a new filter. Transfusion 1990;30:30-33.
19. Escolar G, Bastida E, Castillo R, Ordinas A: Development of a computer program to analyze the parameters of platelet vessel wall interaction. Haemostasis 1986;16:8-14
20. Baumgartner HR: Platelet interaction with collagen fibrils in flowing blood. I. Reaction of human platelets with α-chymotrypsin-digested subendothelium. Thromb Hacmost 1977;37:1-7.
21. Clauss A: Gerinnungsphysiologische Schnellmethode zur Bestimmang des Fibrinogens Acta Haematol 1957;17:237-247.
22. Pelzer H, Schwartz A, Stüber W: Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemost 1991;65:153-159.
23. Reverter JC, Escolar G, Sanz C, Cases A, Villamor N, Nieuwenhuis HK, López J, Ordinas A: Platelet activation during hemodialysis measured through exposure of P-selectin: Analysis by flow cytometry and ultrastructural techniques. J Lab Clin Med 1994;124:79-85.
24. Duke WW: The relation of blood platelets to hemorrhagic disease: Description of a method for determining the bleeding time and coagulation time and report of three cases of hemorrhagic disease relieved by transfusion. JAMA 1910;55:1185-1192.
25. Ivy AC, Nelson D, Bucher G: The standardization of certain factors in the cutaneous 'venostasis' bleeding time technique. J Lab Clin Med 1941;26-1812-1822.
26. Born GVR: The aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962;927:929.
27. Hellem AJ: The adhesiveness of human blood platelets in vitro. Scand J Clin Lab Invest 1960; 51:12.
28. Salzman EW: Measurements of platelet adhesiveness. A simple in vitro technique demonstrating an abnormality in von Willebrand's disease. J Lab Clin Med 1963;62:724-735.
29. Weiss HJ, Turitto VT, Baumgartner HR: Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium Studies utilizing patients with quantitative and qualitative platelet defects. J Clin Invest 1986;78:1072-1082.
30. Bode AP, Read MS, Lust RM: Hemostatic properties of lyophilized platelets in tests of bleeding times. Transfusion 1993;33:S307-S312.
31. Read MS, Reddick RL, Bude AP, Bellinger DA, Nichols TC, Taylor K, Smith SV, Mcmahon DK, Griggs TR, Brinkhous KM: Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: Potential for long-term storage of dried platelets for transfusion. Proc Natl Acad Sci USA 1995;92:397-401.
32. Rinder HM, Snyder EL, Bunan JL, Napychank PA, Malkus H, Smith BR: Activation in stored platelets concentrates: Correlation between membrane expression P-selectin. GPIIb-IIIa and β-thromboglobulin release Transfusion 1993;33:25-29.
33. Rand MD, Kalafatis M, Mann KG: Platelet coagulation factor Va the major secretory platelet phosphoprotein. Blood 1994;83:2180-2190.
34. Nemerson Y: Analysis of the kinetics of factor X activation by tissue factor-factor VIIa. Haemostasia 1996;26(suppl 4):98-101
35. Sims PJ, Faioni EM, Wiedmer T, Shatill SJ: Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation Va and express prothrombinase actvity J Biol Chem 1988;34:18205-18212.
36. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ: Assembly of the platelet prothrombinase complex is linked to vesiculation ot the platelet plasma membrane. Studies, in Scott syndrome: An isolated defect in platelet procoagulant activity. J Biol Chem 1989:264:17049-17057.
37. Owens MR, Holme S, Cardinali S: Platelet microvesicles adhere to subendothelium and promote adhesion of platelets. Thromb Res 1992; 66:247-258.
38. Me Gill M, Fugman DA, Vittorio W, Darrow C: Platelet membrane vesicles reduced microvascular bleeding times in thrombocytopenic rabbits. J Lab Clin Med 1987;109:127-133
39. Jy W. Horstman LL, Arce M, Ahn YS: Clinical significance of platelet microparticles in autoimmunc thrombocytopenias. J Lab Clin Med 1992,119:334-345